It's likely to be a rough day for Intuitive Surgical (ISRG) which is off 14% premarket following...


It's likely to be a rough day for Intuitive Surgical (ISRG) which is off 14% premarket following Thursday evening's Q2 report. Although the disclosure of an FDA warning letter on the CC was the catalyst for an AH sell-off, the company also cut its FY13 revenue guidance markedly to 0-7% growth from 16-19% and slashed its outlook for procedure growth to 15-18% from 20-23%. The shares were downgraded to Underperform at JMP this morning; price target is $275. (transcript)

From other sites
Comments (1)
  • Andyzhu
    , contributor
    Comments (13) | Send Message
     
    Intuitive Surgical price target lowered to $530 from $625 at JPMorgan

     

    Intuitive Surgical price target lowered to $425 from $575 at Cantor

     

    Why dies SA always have to "communicate" the most sensational "info"
    19 Jul 2013, 09:30 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs